[
  {
    "ts": "2025-11-06T04:01:36+00:00",
    "headline": "Incyte (INCY): Buy, Sell, or Hold Post Q3 Earnings?",
    "summary": "The past six months have been a windfall for Incyte’s shareholders. The company’s stock price has jumped 78.7%, setting a new 52-week high of $106.50 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
    "url": "https://finance.yahoo.com/news/incyte-incy-buy-sell-hold-040136318.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "12cdcfd0-0955-3eec-9b67-50acd90ab478",
      "content": {
        "id": "12cdcfd0-0955-3eec-9b67-50acd90ab478",
        "contentType": "STORY",
        "title": "Incyte (INCY): Buy, Sell, or Hold Post Q3 Earnings?",
        "description": "",
        "summary": "The past six months have been a windfall for Incyte’s shareholders. The company’s stock price has jumped 78.7%, setting a new 52-week high of $106.50 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
        "pubDate": "2025-11-06T04:01:36Z",
        "displayTime": "2025-11-06T04:01:36Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/dd5ed23043756cdda4b65d5c228863e0",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "INCY Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9ebFa.LFGXWDaOAygGvuNg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/dd5ed23043756cdda4b65d5c228863e0.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ojCguUNIH7INClq6_Rac1A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/dd5ed23043756cdda4b65d5c228863e0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/incyte-incy-buy-sell-hold-040136318.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/incyte-incy-buy-sell-hold-040136318.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "INCY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-06T14:15:00+00:00",
    "headline": "Incyte’s Moments of Clarity Program Expands to Highlight Powerful Patient Stories in Vitiligo and Pediatric Eczema",
    "summary": "WILMINGTON, Del., November 06, 2025--Incyte’s Moments of Clarity Program Expands to Highlight Powerful Patient Stories in Vitiligo and Pediatric Eczema",
    "url": "https://finance.yahoo.com/news/incyte-moments-clarity-program-expands-141500021.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "836e45a8-07ed-3bec-8af5-ee9df3ee1dd6",
      "content": {
        "id": "836e45a8-07ed-3bec-8af5-ee9df3ee1dd6",
        "contentType": "STORY",
        "title": "Incyte’s Moments of Clarity Program Expands to Highlight Powerful Patient Stories in Vitiligo and Pediatric Eczema",
        "description": "",
        "summary": "WILMINGTON, Del., November 06, 2025--Incyte’s Moments of Clarity Program Expands to Highlight Powerful Patient Stories in Vitiligo and Pediatric Eczema",
        "pubDate": "2025-11-06T14:15:00Z",
        "displayTime": "2025-11-06T14:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/68f4a9545c9215a682de79124ca0c76e",
          "originalWidth": 1920,
          "originalHeight": 1080,
          "caption": "Sarah shares her vitiligo journey for Incyte’s Moments of Clarity program",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LVADcpwcAeyC9qVD3wIn2A--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/business-wire.com/68f4a9545c9215a682de79124ca0c76e.cf.webp",
              "width": 1920,
              "height": 1080,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iqK_Bmd9SAZ9qEmIHj_VuA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/68f4a9545c9215a682de79124ca0c76e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/incyte-moments-clarity-program-expands-141500021.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/incyte-moments-clarity-program-expands-141500021.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "INCY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-06T15:12:01+00:00",
    "headline": "Is It Time to Reevaluate Incyte After Strong Pipeline Update and 52% Price Surge?",
    "summary": "Wondering whether Incyte is priced right, or if the market is missing something? You're not alone. This is one biotech that has investors talking about value. The stock has surged 17.2% in just the past week, racking up a 52.0% gain year-to-date and rising 30.6% over the last twelve months. This has prompted many to reconsider its growth potential and risk profile. Much of this momentum came on the heels of positive headlines around recent product pipeline updates and strategic partnerships...",
    "url": "https://finance.yahoo.com/news/time-reevaluate-incyte-strong-pipeline-151201315.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "7fb0be3d-073a-31d6-abb2-b66a9272de93",
      "content": {
        "id": "7fb0be3d-073a-31d6-abb2-b66a9272de93",
        "contentType": "STORY",
        "title": "Is It Time to Reevaluate Incyte After Strong Pipeline Update and 52% Price Surge?",
        "description": "",
        "summary": "Wondering whether Incyte is priced right, or if the market is missing something? You're not alone. This is one biotech that has investors talking about value. The stock has surged 17.2% in just the past week, racking up a 52.0% gain year-to-date and rising 30.6% over the last twelve months. This has prompted many to reconsider its growth potential and risk profile. Much of this momentum came on the heels of positive headlines around recent product pipeline updates and strategic partnerships...",
        "pubDate": "2025-11-06T15:12:01Z",
        "displayTime": "2025-11-06T15:12:01Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FqD7IP1YjoMtOLiC1foWBQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DnvRJ7zmyZqa8oFdfcLgCg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/time-reevaluate-incyte-strong-pipeline-151201315.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/time-reevaluate-incyte-strong-pipeline-151201315.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "INCY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]